This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57350730
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 2015 article scientifique publié en 2015 im Februar 2015 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q57350730-C3A75A05-2DAA-4218-B221-5A2EB2D382C6
wdt:P577
2015-02-01T00:00:00Z
p:P2093
wds:Q57350730-51B5323E-963C-4802-AABD-B541F0992977 wds:Q57350730-48CC92DD-C9B6-47D9-B2F4-8DDE34A700A5 wds:Q57350730-73FF44FB-1295-4919-A748-2F37DF874FD8 wds:Q57350730-356BEFBC-E527-43A1-8FF5-A47DFD1BC51F
wdt:P2093
Guiying Li Minyi Qi NaNa Yu Xunyong Liu
rdfs:label
Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release
skos:prefLabel
Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release
schema:name
Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release
p:P1476
wds:Q57350730-B3663FB8-2A8F-443C-B716-0CEC6EEC2059
wdt:P1476
Hybrid vesicles co-assembled from anionic graft copolymer and metal ions for controlled drug release
p:P304
wds:Q57350730-377D98CD-7FC5-4833-8753-729CB7589000
wdt:P304
710-715
p:P31
wds:Q57350730-EA9B69DC-91BC-499F-8060-ECC399AA1EA8
wdt:P31
wd:Q13442814
p:P921
wds:Q57350730-5AF81051-457F-498A-A074-0CEE97EC92A7 wds:Q57350730-16D1EFB5-88ED-4702-A8B3-7DBAB4B0933F
wdt:P921
wd:Q321355 wd:Q909510
p:P1433
wds:Q57350730-2CF9D052-B28B-476B-AA64-8E264AEC6EB1
wdt:P1433
wd:Q15755357
p:P478
wds:Q57350730-D637B891-59B8-427E-AABB-AAC2049D9771
wdt:P478
262
p:P356
wds:Q57350730-8C54584F-4CC3-4A04-8EBA-D751184843F7
wdtn:P356
n8:J.CEJ.2014.10.029
wdt:P356
10.1016/J.CEJ.2014.10.029